Research Paper Volume 12, Issue 9 pp 8640—8651

Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models

class="figure-viewer-img"

Figure 2. Exenatide treatment improves cardiomyocytes function under hyperglycemia stress. (AD) Signal of cardiomyocyte contractile parameters measured in response to Exenatide treatment. (E, F) Myosin expression determined through immunofluorescence. *P<0.05.